Investing
The company will expand its team and product offerings, including direct-to-consumer operations, thanks to the FDA's approval of over-the-counter sales of hearing aids.
The company said it will use the funding to accelerate its go-to-market push.
The company will expand its team by 300% by 2023 and expand the rollout of its services in the U.S. market.
The pre-seed will be used to expand the startup's clinical operations and research as well as improve its proprietary clinical protocols.
The company also announced a partnership with managed care organization CareSource to study the benefits of using virtual reality with patients receiving home and community-based services.
The company received the funds as part of growth equity financing.
HealthJoy, Hazel Health, Navina, Galen Robotics, Midi Health and Lumata Health also announced funding rounds.
HSS announced it raised $21 million in Series A funds to launch the new company.
Noala, Elion and Upheal also announced funding rounds.
The company will speed up its clinical trial recruitment measures, raise awareness of post-approval treatments and support cancer research.